Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease. - Wikidata - wikimedia - TriplyDB

Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease.

Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease.

http://www.wikidata.org/entity/Q46460979

about

Evidence for the prevention and treatment of stroke in dialysis patients Switching patients with non-dialysis chronic kidney disease from oral iron to intravenous ferric carboxymaltose: effects on erythropoiesis-stimulating agent requirements, costs, hemoglobin and iron status CKD classification based on estimated GFR over three years and subsequent cardiac and mortality outcomes: a cohort study.Inflammation and cardiovascular events in individuals with and without chronic kidney disease.Cardiovascular co-morbidity in chronic kidney disease: Current knowledge and future research needs.An update on the controversies in anemia management in chronic kidney disease: lessons learned and lost.Predicting mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry.Comparison of plasma oxidative biomarkers and conformational modifications of hemoglobin in patients with diabetes on hemodialysis Association between Hemoglobin Concentration and the Progression or Development of Albuminuria in Diabetic Kidney Disease.Albuminuria as a Risk Factor for Anemia in Chronic Kidney Disease: Result from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD)Anemia as an Independent Predictor of Adverse Cardiac Outcomes in Patients with Atrial Fibrillation Effect of frequent or extended hemodialysis on cardiovascular parameters: a meta-analysis.Uric acid and incident kidney disease in the community.Negative trials in nephrology: what can we learn?Left ventricular hypertrophy in mild and moderate reduction in kidney function determined using cardiac magnetic resonance imaging and cystatin C: the multi-ethnic study of atherosclerosis (MESA)Cardiovascular disease in patients with chronic kidney disease: a neglected subgroup.Left ventricular geometry predicts cardiovascular outcomes associated with anemia correction in CKD.The effect of vitamin C on parathyroid hormone in patients on hemodialysis with secondary hyperparathyroidism: a double blind, placebo-controlled study.Cardiovascular risk factors and prevention of cardiovascular disease in patients with chronic renal disease.Hypertension, left ventricular hypertrophy and chronic kidney disease.Phosphate in early chronic kidney disease: associations with clinical outcomes and a target to reduce cardiovascular risk.The importance of accurate measurement of aortic stiffness in patients with chronic kidney disease and end-stage renal disease.Associations of Conventional Echocardiographic Measures with Incident Heart Failure and Mortality: The Chronic Renal Insufficiency Cohort.Association of Anemic Hypoxia and Increased Pulmonary Artery Systolic Pressure in Patients With Systemic Lupus Erythematosus.Association of Pulmonary Hypertension with Mortality in Incident Peritoneal Dialysis Patients.Post-renal transplantation anemia at 12 months: prevalence, risk factors, and impact on clinical outcomes.Reliability of blood pressure parameters for dry weight estimation in hemodialysis patients.Analysis of early kidney damage in hospitalized patients with chronic kidney disease: a multicenter study.Rat parathyroid hormone 1-34 signals through the MEK/ERK pathway to induce cardiac hypertrophy.Could intradialytic nutrition improve refractory anaemia in patients undergoing haemodialysis?Association of Hemoglobin Concentration and Its Change With Cardiovascular and All-Cause Mortality.The relationship between anemia and pulse pressure and hypertension: The Korea National Health and Nutrition Examination Survey 2010-2012.Rationale and study design of a randomized controlled trial to assess the effects of maintaining hemoglobin levels using darbepoetin alfa on prevention of development of end-stage kidney disease in non-diabetic CKD patients (PREDICT Trial).Endothelial activation markers in anemic non-dialysis chronic kidney disease patients.A threshold trajectory was revealed by isolating the effects of hemoglobin rate of rise in anemia of chronic kidney disease.Kardiorenales Syndrom Prevalence, characteristics and prognostic significance of anemia in daily practice Novel Compound Induces Erythropoietin Secretion through Liver Effects in Chronic Kidney Disease Patients and Healthy Volunteers

P2860

Q27023274-50583D47-BAFF-43C3-A5D5-EDBECD383DC3 Q28648176-7CE61A58-66EA-40AF-923C-413103A9BD25 Q33504418-535F96DA-B39F-4EDA-95E3-F14E9C04174B Q33852631-99395B49-0AF9-4537-A7C7-853C70287492 Q34453236-50C0207A-1F8F-4784-9F1B-940242A03ABD Q34896347-8D7EED18-76AF-48E4-AB14-F909A26DB673 Q35000643-5E81B3FD-3444-405D-90AC-4F3D99893CEE Q35087619-836DB9DE-8DBE-4B49-8181-70D821D9E5AA Q35646060-5785484C-3711-4CAB-A18C-0A3375144B59 Q35796736-1192AFD3-EC57-4B0E-9FF9-6729BA615AE6 Q35942115-E89C22A5-6E3D-4970-89E5-78C51EAC710E Q36090656-E54DCEB3-FBBE-43F0-A642-FB58B113D4A6 Q36677662-7DC95213-BA46-466D-AE28-9817BD753848 Q36863406-8AD3CCF9-AE4B-433B-BCAB-A4B44BE6FE15 Q37002467-3BC8F609-37FF-4BF9-8751-625B16958B34 Q37463969-EB6478B0-AB18-46B5-B6F6-FD46FC80FD64 Q37477724-81A22266-4789-4DBF-A8C7-CCDA4F3422AA Q37639134-80863ED6-E86F-4BCC-BC64-F36A13F5E56C Q37738896-B36338FE-058A-4465-A9B8-61E88CA18260 Q37813472-F667CEF7-3F68-4CA9-8E4E-D23B73A8F1AF Q38009044-5CF00BFA-9246-4811-B9DD-83CE6B2D18C8 Q38635835-D1177DEB-328D-4029-953C-A69A25AA3532 Q38978842-386F6B4B-BF34-4278-BF6B-1549EC6AE68F Q40896042-579966B2-5B7C-4713-B386-5E09CEA882A7 Q41109950-BB15D4FF-14DE-4C68-909B-5B12BEA4C4DA Q41511526-F0261076-5C01-47E6-8BFE-9BA6EA2DBD14 Q44354054-D2F23BF1-09FD-418D-B429-22C168E61D6F Q45398408-AAA384DB-C5B7-43CA-848C-AA33ED8933D8 Q46334588-6439B517-004D-46EB-8E64-291FD00263E1 Q46734772-9983D37A-FF52-43E1-BCF3-593A7E6DADA4 Q49598677-09E7C2A3-85B5-42E8-81A2-DDDFDD4E3A12 Q50106749-E8A2A4EF-70DF-4C5D-B811-8057216E40FC Q50442683-E783FD31-3881-4511-889E-D8A75515A447 Q53442889-0AA505DE-0AC5-4437-A5FE-918CEF939F31 Q54961659-F420EF3F-2848-4A7B-ACA6-838B6F103C0E Q56686664-B340748F-4361-4D19-B0F6-87B1A9ED7567 Q57612895-EEB57BED-5EF5-4C94-BA9D-C495575AB37A Q58765839-C69B4D97-7805-413B-9164-63F8038319A8

P2860

Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease.

http://www.wikidata.org/entity/Q46460979

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Effects of anemia and left ven ...... s with chronic kidney disease.

@en

Effects of anemia and left ven ...... s with chronic kidney disease.

@nl

type

label

Effects of anemia and left ven ...... s with chronic kidney disease.

@en

Effects of anemia and left ven ...... s with chronic kidney disease.

@nl

prefLabel

Effects of anemia and left ven ...... s with chronic kidney disease.

@en

Effects of anemia and left ven ...... s with chronic kidney disease.

@nl

P1433

Q46460979-85360933-BA3F-47C0-862A-247BD56F3B37

P1476

Q46460979-22BB76E3-0135-42DF-9F32-B8410B150C68

P2093

Q46460979-0A9B37C7-6C42-4072-B721-FC90BD59F509

Q46460979-0F763A61-C27D-4D46-9963-CBE8587B9EE0

Q46460979-3BEBDBFD-CA07-4B85-A743-818396CF4521

Q46460979-498277D7-C3EB-4E3B-96D7-5CD49055BA76

Q46460979-96BB4348-F1CA-48F5-853C-44A339DD276F

Q46460979-A3EEFED4-FD48-4FAD-AEFC-ADAC728CD1A6

Q46460979-FA85B27D-FDBE-416D-B219-8E5DD65CD18D

P304

Q46460979-6BC86163-5869-4F1D-AC18-AD94C05613E1

P31

Q46460979-288EFC24-2D71-4F5C-BD34-F1504AD9646F

P356

Q46460979-590A63A0-2C23-4B6A-AD42-92894E5E44F6

P433

Q46460979-E47BA099-AB6D-4F8F-98A2-28D1D2E49342

P478

Q46460979-6E283E73-69AC-407E-BF24-BEBDA62CE027

P577

Q46460979-CBBED0C6-823D-4C48-9FC3-D3A6852F4272

P698

Q46460979-49FE2486-D55E-4219-8F3D-8E6EBB0E5CD8

P921

Q46460979-088B42D6-40F2-4034-8D7A-AF6021785C40

Q46460979-519DC22C-156C-4341-B457-DB1410EBA315

P356

P1433

Journal of the American Society of Nephrology

P1476

Effects of anemia and left ven ...... s with chronic kidney disease.

@en

P2093

Andrew S Levey

http://www.w3.org/2001/XMLSchema#string

Daniel E Weiner

http://www.w3.org/2001/XMLSchema#string

Deeb N Salem

http://www.w3.org/2001/XMLSchema#string

Hocine Tighiouart

http://www.w3.org/2001/XMLSchema#string

John L Griffith

http://www.w3.org/2001/XMLSchema#string

Mark J Sarnak

http://www.w3.org/2001/XMLSchema#string

Panagiotis T Vlagopoulos

http://www.w3.org/2001/XMLSchema#string

P304

1803-1810

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2004070597

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2005-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15857925

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease